PMCPA Case
| Case number | AUTH/2584/3/13 |
| Complainant | Clinical pharmacist |
| Company | Almirall |
| Material / activity | Invitation to a meeting (regional launch meeting) |
| Medicine | Eklira Genuair (aclidinium bromide inhalation powder) |
| Therapy area | COPD |
| Main issue | Whether the invitation blurred education vs promotion / disguised promotion; whether Clause 18.4 applied |
| Clauses considered | Clause 12.1 and Clause 18.4 |
| Decision | No breach of the Code |
| Complaint received | 7 March 2013 |
| Case completed | 16 April 2013 |
| Applicable Code year | 2012 |
Download the full case report (PDF)
Reviewed by Dr Anzal Qurbain (FFPM) β ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors β instant answers, 24/7.
⭐ Business Intelligence Access
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.
One real case. One key lesson. Every week β free.